Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 155,344
  • Shares Outstanding, K 55,480
  • Annual Sales, $ 15,550 K
  • Annual Income, $ -67,140 K
  • 36-Month Beta 1.04
  • Price/Sales 9.99
  • Price/Cash Flow 0.00
  • Price/Book 5.90

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.30 +21.74%
on 09/19/17
3.30 -15.15%
on 08/23/17
-0.30 (-9.68%)
since 08/22/17
3-Month
2.30 +21.74%
on 09/19/17
3.60 -22.22%
on 07/24/17
-0.05 (-1.75%)
since 06/22/17
52-Week
1.50 +86.67%
on 11/23/16
3.60 -22.22%
on 07/24/17
+0.35 (+14.29%)
since 09/22/16

Most Recent Stories

More News
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences.

BDSI : 2.80 (unch)
BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that Health Canada has granted market authorization to formally transfer the Drug Identification Number (DIN) ownership of BELBUCA®...

BDSI : 2.80 (unch)
BioDelivery Sciences Presents Data on BELBUCA® (buprenorphine) Buccal Film at the PAINWeek 2017 Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) presented three posters including results from an analysis of data which evaluated the reported adverse respiratory effects of BELBUCA® (buprenorphine)...

BDSI : 2.80 (unch)
Corporate News Blog - BioDelivery Sciences CEO Dr. Mark A. Sirgo to Retire at Year-End; Will Continue as Vice Chairman

Research Desk Line-up: Abeona Therapeutics Post Earnings Coverage

ABEO : 14.95 (-7.72%)
BDSI : 2.80 (unch)
BioDelivery (BDSI) CEO Mark Sirgo to Retire by 2017 End

BioDelivery Sciences (BDSI) President and CEO, Mark Sirgo, is set to retire this year.

CORT : 18.20 (+3.94%)
COLL : 10.31 (+2.49%)
ENDP : 8.66 (-1.59%)
BDSI : 2.80 (unch)
BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at the Rodman & Renshaw 19th Annual Global Investment...

BDSI : 2.80 (unch)
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI's President and Chief Executive Officer, roles which he has held since...

BDSI : 2.80 (unch)
Analyzing the Financial Health of Biotech Companies

LAS VEGAS, August 17, 2017 /PRNewswire/ --

AQXP : 13.75 (+0.88%)
BDSI : 2.80 (unch)
ZIOP : 6.17 (+1.82%)
PPCB : 0.2900 (-4.13%)
CPRX : 2.44 (unch)
Analyzing the Financial Health of Biotech Companies

The business and technology behind the biotechnology industry is multifaceted and uncertain. This makes analyzing a biotech company's future success a challenging job. What makes this task even more difficult...

AQXP : 13.75 (+0.88%)
BDSI : 2.80 (unch)
PPCB : 0.2900 (-4.13%)
ZIOP : 6.17 (+1.82%)
CPRX : 2.44 (unch)
BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) will present three posters reviewing the potential impacts of BELBUCA® (buprenorphine) buccal film (CIII) and BUNAVAIL® (buprenorphine and naloxone)...

BDSI : 2.80 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators are in flux.

See More

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Support & Resistance

2nd Resistance Point 2.93
1st Resistance Point 2.87
Last Price 2.80
1st Support Level 2.69
2nd Support Level 2.58

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.